Treatment of actinic keratoses and cancerization field of the face and scalp with 0.015% ingenol mebutate gel in Brazilian individuals: safety, tolerability and patients' perspectives

Treatment of actinic keratoses and cancerization field of the face and scalp with 0.015% ingenol mebutate gel in Brazilian individuals: safety, tolerability and patients' perspectives

Abstract: Background: Actinic keratosis (AK) represents a risk of progression to squamous cell carcinoma. Ingenol mebutate gel is a novel therapeutic option for field-directed treatment. Objectives: To evaluate the safety, tolerability and patients' perspectives, related to the therapeutic su...

Full description

Bibliographic Details
Main Authors:	Luiz Gameiro, Luis Fernando Requejo Tovo, José Antonio Sanches Júnior, Ivan Aprahamian
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Dermatologia 2019-07-01
Series:	Anais Brasileiros de Dermatologia
Subjects:	Keratosis, actinic Face Medication adherence Patient compliance Precancerous conditions Skin neoplasms
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962019000300313&tlng=en

Similar Items

Ingenol mebutate in the treatment of actinic keratoses: clearance rate and adverse effects
by: Maria Isabel Ramos Saraiva, et al.
Published: (2018-08-01)

Ingenol mebutate: A novel topical drug for actinic keratosis
by: Suruchi Aditya, et al.
Published: (2013-01-01)

Intense pustular reaction during treatment of actinic keratosis with ingenol mebutate
by: Dorota Jaśkiewicz-Nyckowska, et al.
Published: (2015-06-01)

Ingenol mebutate in low amounts for the treatment of actinic keratosis in Korean patients
by: Joe HJ, et al.
Published: (2017-03-01)

Management of actinic cheilitis using ingenol mebutate gel: A report of seven cases
by: Ángeles Flórez, et al.
Published: (2017-02-01)

Actinic keratoses: review of clinical, dermoscopic, and therapeutic aspects,
by: Clarissa Prieto Herman Reinehr, et al.
Published: (2020-02-01)

Ingenol mebutate–associated immune thrombocytopenic purpura
by: Hafsa Zuberi, BS, et al.
Published: (2024-04-01)

Clinical utility of ingenol mebutate in the management of actinic keratosis: perspectives from clinical practice
by: Skroza N, et al.
Published: (2018-10-01)

Ingenol mebutate treatment for actinic cheilitis: clinical, histopathological and p53 profile of 14 cases
by: Rita de Cassia Rossini, et al.
Published: (2021-11-01)

Ingenol mebutate for the treatment of actinic keratosis: effectiveness and safety in 246 patients treated in real-life clinical practice
by: Rosa Ortega del Olmo, et al.
Published: (2018-05-01)

Pharmacokinetics of ingenol mebutate gel under maximum use conditions in large treatment areas
by: Alicia D. Bucko, et al.
Published: (2018-01-01)

Efficacy of ingenol mebutate gel for actinic keratosis in patients treated by thiazide diuretics
by: Campione E, et al.
Published: (2016-11-01)

Relationship between severity of the local skin reactions and the rate of local skin reaction resolution in patients treated with ingenol mebutate gel
by: Jim On SC, et al.
Published: (2016-08-01)

Optimal treatment of actinic keratoses
by: Uhlenhake EE
Published: (2013-01-01)

Ablative fractional laser improves treatment of actinic keratoses with Ingenol Mebutate
by: Steven Nisticò, et al.
Published: (2016-12-01)

Poor Adherence to Self-Applied Topical Drug Treatment Is a Common Source of Low Lesion Clearance in Patients with Actinic Keratosis—A Cross-Sectional Study
by: Elias A. T. Koch, et al.
Published: (2023-06-01)

Nodular basal cell carcinoma of the face successfully treated with ingenol mebutate 0.015% gel
by: Silvia S. Iannazzone, et al.
Published: (2018-04-01)

Efficacy of new class I medical device for actinic keratoses: a randomized controlled prospective study
by: Federica Veronese, et al.
Published: (2021-08-01)

Actinic keratoses - a systemic review
by: T. . Strunk, et al.
Published: (2017-08-01)

Preliminary Evidence of Efficacy, Safety, and Treatment Satisfaction with Tirbanibulin 1% Ointment: A Clinical Perspective on Actinic Keratoses
by: Elena Campione, et al.
Published: (2023-12-01)

Topical treatment of actinic keratoses with potassium dobesilate 5% cream. a preliminary open-label study
by: Cuevas P, et al.
Published: (2011-02-01)

Tumor-Preferential Induction of Immune Responses and Epidermal Cell Death in Actinic Keratoses by Ingenol Mebutate.
by: Steffen Emmert, et al.
Published: (2016-01-01)

Ingenol mebutate induces a tumor cell-directed inflammatory response and antimicrobial peptides thereby promoting rapid tumor destruction and wound healing
by: Stephan Alexander Braun, et al.
Published: (2018-09-01)

Actinic keratosis: аctual view
by: T. V. Abramova, et al.
Published: (2020-01-01)

A dose-finding trial with a novel ingenol derivative (ingenol disoxate: LEO 43204) for field treatment of actinic keratosis on full face or 250 cm2 on the chest
by: Marc Bourcier, et al.
Published: (2017-10-01)

Management and clinical practice of multiple face and scalp actinic keratosis in France
by: Jacques Savary, et al.
Published: (2019-01-01)

Risk factors for actinic keratoses: A systematic review and meta-analysis
by: Yongshuang Li, et al.
Published: (2022-01-01)

Optimal treatment of actinic keratosis
by: Goldenberg G
Published: (2013-12-01)

Transcriptomic Study on Human Skin Samples: Identification of Two Subclasses of Actinic Keratoses
by: Hélène Dubois-Pot-Schneider, et al.
Published: (2023-03-01)

Comparing efficacy and safety of potassium hydroxide 5% solution with 5-fluorouracil cream in patients with actinic keratoses: a randomized controlled trial
by: Ali Salehi Farid, et al.
Published: (2022-04-01)

Comparative Efficacy and Safety of Tirbanibulin for Actinic Keratosis of the Face and Scalp in Europe: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
by: Markus V. Heppt, et al.
Published: (2022-03-01)

Management Pearls on the Treatment of Actinic Keratoses and Field Cancerization
by: Jaime Piquero-Casals, et al.
Published: (2020-07-01)

Clinical characteristics of actinic keratoses and their histological correlations: suggestion for a clinical severity scale
by: Guilherme de Oliveira Arruda, et al.
Published: (2022-12-01)

Actinic Keratoses (AK): An Exploratory Questionnaire-Based Study of Patients’ Illness Perceptions
by: Dimitrios Sgouros, et al.
Published: (2022-07-01)

Efficacy of topical imiquimod 3.75% in the treatment of actinic keratosis of the scalp in immunosuppressed patients: our case series
by: E. Zavattaro, et al.
Published: (2020-04-01)

Sequential Treatment of Multiple Actinic Keratoses with Solaraze and Actikerall
by: Thomas Dirschka, et al.
Published: (2014-07-01)

1% Tirbanibulin Ointment for Actinic Keratoses on Upper Extremities: A Retrospective Case Review Study
by: Álvaro Iglesias-Puzas, et al.
Published: (2023-10-01)

A randomized split-face clinical trial of conventional vs indoor-daylight photodynamic therapy for the treatment of multiple actinic keratosis of the face and scalp and photoaging
by: M. Arisi, et al.
Published: (2022-05-01)

Systematic Literature Review and Network Meta-analysis of the Efficacy and Acceptability of Interventions in Actinic Keratoses
by: Khaled Ezzedine, et al.
Published: (2021-01-01)

Educational video promotes durable knowledge about actinic keratoses in patients with field cancerization: a pseudorandomized, single-blind, controlled pilot study
by: Benjamin J. Kahn, et al.
Published: (2022-01-01)